A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada


Adaptive radiation therapy in clinical practice

The 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists in Banff brought together professionals working across radiation oncology, imaging, treatment planning, and quality assurance. Within that setting, abstracts on adaptive radiation therapy reflected a field moving from promising research toward practical clinical use.

Adaptive radiation therapy (ART) refers to the adjustment of a patient’s treatment plan in response to anatomical changes, biological variation, or treatment-related effects observed during a course of radiotherapy. These changes can include tumour shrinkage, weight loss, organ motion, altered filling of the bladder or rectum, and shifts in target or organ-at-risk position.

The clinical value of ART lies in its ability to preserve intended target coverage while reducing unnecessary dose to healthy tissue. The abstracts associated with this theme are best understood as reports about workflows: how to identify meaningful change, decide when replanning is justified, and deliver a revised plan safely within the constraints of a busy department.

From static plans to responsive treatment

Conventional radiotherapy generally relies on a plan created before treatment begins and applied over multiple fractions. That approach remains effective for many patients, yet it assumes that anatomy and treatment conditions will remain sufficiently stable. In reality, the geometry seen at simulation may differ from the geometry present on a later treatment day.

Clinical implementation of ART introduces a feedback loop. New imaging is acquired, the anatomy is assessed, the original plan is reviewed against current conditions, and a decision is made to continue, modify, or replace the plan. This process can be performed prospectively at scheduled intervals or triggered by a specific anatomical change.

The abstracts’ emphasis on implementation is important because adaptive treatment is more than a software feature. It requires agreed thresholds, trained staff, reliable image registration, efficient contour review, and a documented approval process. Without those elements, frequent replanning can create delay without producing a meaningful dosimetric or clinical benefit.

Imaging and the identification of change

Image guidance is the foundation of adaptive workflows. Cone-beam CT, repeat diagnostic CT, magnetic resonance imaging, and other volumetric techniques can reveal changes that are not apparent from external marks or setup shifts alone. The relevant question is not simply whether anatomy has changed, but whether that change affects target coverage or normal-tissue exposure.

For head-and-neck treatment, examples may include progressive weight loss, reduced tumour volume, altered shoulder position, or changing parotid anatomy. In pelvic treatment, bladder and rectal filling can affect the location of the prostate, cervix, uterus, or nearby bowel. For thoracic cases, respiratory motion and variations in lung volume may influence both target position and dose distribution.

An adaptive radiation therapy abstract may therefore focus on image review criteria, deformable image registration, or automated segmentation. Each tool has limitations. Registration can propagate uncertainty, while automatic contours require careful clinical checking. A robust workflow treats these technologies as decision-support tools rather than substitutes for professional judgement.

Replanning decisions and workflow design

A central implementation issue is determining when adaptation is worth the time and resources. A small anatomical change may have little dosimetric consequence, while a seemingly modest shift can compromise a critical structure. Departments may use dose-volume thresholds, target undercoverage criteria, geometric indicators, or physician and physicist review to trigger replanning.

The timing of adaptation also varies by disease site and treatment technique. Some patients benefit from an early repeat scan because substantial change is expected during therapy. Others may require adaptation only after image guidance identifies a persistent mismatch. Online adaptation, performed during the treatment session, can offer a highly responsive solution but demands rapid contouring, plan optimization, verification, and approval.

Offline adaptation is generally easier to integrate into existing practice. It allows a revised plan to be prepared between fractions, with additional time for review and quality control. The trade-off is that the patient’s anatomy may continue to change before the new plan is ready. Abstracts examining these approaches help define which cases justify greater operational complexity.

Comparing adaptive strategies

The most suitable model depends on equipment, staffing, disease site, treatment intent, and the magnitude of anatomical variation. The comparison below summarizes common approaches discussed in clinical adaptive radiotherapy programs.

Adaptive strategy Typical trigger Main strength Principal limitation
Scheduled offline replanning Repeat imaging at a defined fraction or interval Predictable and easier to organize May miss rapid or unexpected changes
Triggered offline replanning Dosimetric or geometric threshold is exceeded Uses resources for patients who need them Requires dependable review criteria
Online adaptation Anatomy changes during the treatment visit Responds immediately to current anatomy Requires advanced technology and a highly coordinated team
Library or plan-of-the-day approach Daily anatomy matches one of several prepared plans Faster than full replanning Depends on accurate plan selection and adequate plan coverage
Deformable dose accumulation Repeated imaging demonstrates anatomical variation Estimates cumulative delivered dose Sensitive to registration and contouring uncertainty

No single strategy is universally superior. A plan-of-the-day method may be practical for a selected pelvic population, whereas a head-and-neck service may favour scheduled replanning after measurable weight loss. The strongest clinical programs align the adaptive method with a clearly defined failure mode.

Dosimetric gains and patient selection

The expected benefit of ART is usually expressed through improved target conformity, better target coverage, or reduced dose to organs at risk. In head-and-neck radiotherapy, adaptive planning may help limit dose to salivary glands and other normal tissues. In pelvic treatment, it may reduce exposure to bowel, bladder, or rectum when anatomy changes substantially.

Yet a lower predicted dose does not automatically translate into a better patient outcome. The benefit must be weighed against additional imaging, staff time, treatment interruptions, and the possibility of introducing new uncertainties during contouring or plan transfer. A clinically useful abstract should therefore connect dosimetric findings to a decision rule or patient-selection strategy.

Selection may be based on tumour site, baseline anatomy, treatment modality, fractionation, or early-treatment indicators. Patients with large expected anatomical changes are more likely to benefit than those whose geometry remains stable. Risk-based selection can help a department build an ART service without requiring every patient to undergo a complex adaptive pathway.

The work presented at a professional meeting also benefits from multidisciplinary interpretation. Radiation oncologists assess target and disease implications, medical physicists evaluate dose and delivery, radiation therapists manage imaging and treatment execution, and dosimetrists support efficient plan generation. Implementation succeeds when these responsibilities are explicit.

Verification, safety, and quality assurance

Adaptive planning expands the number of decisions made during treatment, which increases the importance of quality assurance. Each revised plan needs checks for contour integrity, dose calculation, monitor units, treatment parameters, image registration, and transfer to the treatment delivery system. The verification process should be proportionate to the speed and complexity of the workflow.

End-to-end testing can reveal failures that are not visible in isolated software checks. A department may test image acquisition, contour propagation, plan optimization, independent dose review, approval, and delivery as one connected process. Version control and clear naming conventions are particularly important when several plans exist for the same patient.

Human factors also deserve attention. A reliable ART service should minimize ambiguous handoffs, define who can approve a plan, and provide escalation procedures when imaging quality or anatomy is unsuitable. These operational details may appear less innovative than a new algorithm, but they determine whether adaptive treatment is safe on an ordinary clinical day.

The wider meeting context reinforced the value of sharing practical results. Recognition of emerging research and technical work can be seen in the poster award winners, whose topics illustrate how conference discussion connects methods, clinical questions, and professional development.

Building a sustainable clinical program

A department considering ART should begin with a narrowly defined clinical problem rather than attempting to adapt every treatment site. A pilot project might focus on patients who frequently experience target displacement or organ-at-risk dose escalation. Baseline data can then establish how often clinically significant changes occur and how much time each adaptive episode requires.

Useful implementation measures include the time from image acquisition to plan approval, the percentage of cases requiring adaptation, the frequency of treatment interruptions, and the change in relevant dose-volume metrics. Patient-reported outcomes and toxicity data become increasingly important as the program matures, because they test whether planning improvements are meaningful beyond the treatment-planning system.

Practical priorities include:

  • Define objective triggers for repeat imaging and replanning.
  • Assign responsibilities for contour review, optimization, approval, and delivery.
  • Validate registration, segmentation, dose accumulation, and plan-transfer tools.
  • Track workflow time, treatment delays, dosimetric effects, and clinical outcomes.
  • Review cases regularly and update thresholds as evidence develops.

Professional meetings also place technical work within the human experience of clinical practice. Delegates attending the Banff meeting could connect scientific discussion with informal exchange and shared professional interests, including the conference’s banquet program. Such interaction can help translate a promising abstract into a collaboration, a protocol, or a carefully designed local trial.

Adaptive radiation therapy remains a clinical strategy shaped by evidence, technology, and judgement. The most valuable implementations are those that identify patients who are likely to benefit, respond to relevant anatomical change, and preserve a transparent safety process. Explore the archived COMP 2014 materials to examine how medical physicists presented these questions and to trace the practical development of adaptive treatment in Canadian radiation oncology.